Croprime Ltd

Accell Clinical Research is an international full-service Contract Research Organization (CRO) managing Phase I-III clinical trials for 10+ years across Eastern Europe. With local presence, including highly qualified medical staff and legal entities in the region, we successfully recruit patients both in EU and outside EU in post-Soviet countries (CIS). All together we provide guaranteed fast patient recruitment in 20+ countries across the region.

⬇︎ ACCELL'S SERVICES for Phase I-III clinical trials:

• Strategic guidance and trial set-up:
• Feasibility research and site selection
• Study documentation development
• Regulatory support
• Clinical supply import and management
• Selection and management of clinical study vendors
• Project management
• Clinical & medical monitoring
• Data management and biostatistics
• Quality assurance
• Safety management
• TMF/eTMF services
• Functional outsourcing of a clinical team

⬇︎ THERAPEUTIC AREAS
• Oncology
• Cardiovascular
• Immunology
• Gastroenterology
• Neurology
• Endocrinology

ANTAEA Group of Companies is one of the largest Regional Clinical Research Organizations (CROs), providing high quality support in Southeast Europe, North Africa, Middle East and the Gulf Area.

The Group provides professional, yet flexible solutions, supporting our Clients to maximize their Research resources, in a cost effective manner. ANTAEA is dedicated to Services of scientific quality, management expertise, precision and reliable technology.

The Group includes integrated, marketing consultation services in our portfolio, based on Market Research, which cover products throughout their life cycle.

Specialities: Feasibility Projects, Initial Submissions, Amendments and Notifications to ECs (local and central) and Regulatory Authorities, Clinical Trials Monitoring in several different phases, Contracts for Clinical Trials Management, Contracts for Clinical Trial Rescue Projects, Design and Development of Clinical Trials Projects, Investigator Initiated Projects, Regulatory & Registration Projects (National, MRP, Variations etc.), Statistical Projects, Contracts for Investigator Training, Contract for Regulatory Services Training, Contract for Site Audit

ANTAEA also provides experienced CRAs to the Pharmaceutical and Biotechnology Industries and to CROs, in all the countries where ANTAEA is operating. ANTAEA training on procedures and setting standards and our technical support, guarantee uniformity in quality and timely delivery of projects.

Founded in 1997, Ergomed plc is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, and Ergomed Clinical Research, a complete, global Phase I-IV clinical development and trial management services with a strong heritage in the development of drugs in rare diseases and oncology.

• 1 300+ highly qualified professionals
• Global full-service CRO
• 24+ years of experience
• Therapeutic specialization in oncology
• Strong expertise in rare disease trials
• Robust clinical safety system
• Choice of leading drug safety databases

Our key services include:
• Clinical Research Services
• Pharmacovigilance
• Medical Information
• Regulatory
• Medical Writing
• Site Management
• Study Physician Support
• Biostatistics
• Patient Study Support

We are a CRO made by people full of passion and enthusiasm for their work. This is the main reason why our customers recommend us to others. The first 20 years of Hippocrates Research paved the way for our Company expertise and our people professional enrichment. Walking that path, we gained awareness of our possibilities and willingness to enthusiastically continue our work. Our wide-range experiences and competences allow us to offer diversified and innovative solutions in order to face our customers’ needs achieving the best results. We operate in 16 countries and 3 continents. Our range of services includes selection and identification of molecules, feasibility studies and project management for Phase I-to-IV Clinical Trials. In addition observational prospective and spontaneous and epidemiological studies. We assist our clients with concept-to-development projects and built-in marketing. Today, after more than 20 years work, we can say that our past was already rich of future!

MONIPOL offers a full range of clinical development and consulting services to a strong customer base of mainly small and medium-sized pharmaceutical, biotechnology, and medical device companies. We are best at tailoring services to your needs.
- Offices in Poland, Germany, and Switzerland.
- ISO 9001:2008 certified.
- GCP-Audits, System-Audits.
- Data Management - Our comprehensive Clinical Data Management solution provides a seamless data collection process, from rapid database launch to high-quality data deliverance, using industry-leading EDC technologies.
- Feasibility - Our local teams offer a deep understanding of the regional clinical dynamics, working alongside you to devise an optimal strategy for your study and identifying ideal trial sites through detailed feasibility studies.
- Functional Service Provisioning - Project Management, Monitoring, Regulatory
- Medical Writing - Our medical writers, drawing on broad industry and academic knowledge, produce timely, cost-effective clinical and regulatory documents, transforming complex data into an accurate, evidence-based account of your drug’s clinical profile.
- Study Start-up - Our study team collaborates with selected sites to collect essential documents, finalize clinical study agreements, and manage submissions and document preparation in parallel, ensuring maximum site initiation at the study’s outset.